Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Science.

Science, Technology and Innovation on NIPMO receiving Excellence in Organisational Contribution to Innovation Management Award
On 4 September 2025, the National Intellectual Property Management Office (NIPMO), a specialised service delivery unit of the Department of Science, Technology and Innovation, received the Southern African Research and Innovation Management...

WARRENSLOVE: Advanced Bio-Signaling Wearables Supported by Scientific Research
WARRENSLOVE: The Science-Backed Bio-Energy Revolution That's Transforming Global Wellness KOWLOON, KOWLOON, HONG KONG, September 15, 2025 /EINPresswire.com/ -- Founded by Warren Hanchey, an expert with over five decades of experience in business...

LogsDay Releases Science-Backed Guide on Safe Supplements for Child Growth and Development
LogsDay’s new guide highlights safe, science-backed supplements to support child growth, immunity, brain health, and overall development PUNE, MAHARASHTRA, INDIA, September 14, 2025 /EINPresswire.com/ -- A newly published guide on LogsDay,...


INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Semler Scientific, Inc. of Class Action Lawsuit and Upcoming Deadlines - SMLR
NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at...

ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SMLR
NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the...

Vidac Pharma Submits Clinical Study Application to EMA for Advanced Actinic Keratosis Lesions
Comprehensive dossier underscores rigorous scientific, clinical, and CMC preparation, with key support from CRO partners Vidac pharma Holding Plc (XSTU:SYM: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ) LONDON, UNITED KINGDOM, September 15, 2025...

Update on Alert: Defibrillation Lead Issue from Boston Scientific
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. This recall involves correcting certain devices and does not involve removing them from where they are used or sold. The FDA has identified this...

Update on Alert: Defibrillation Lead Issue from Boston Scientific
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. This recall involves correcting certain devices and does not involve removing them from where they are used or sold. The FDA has identified this...

Dr. Ryan Williamson Launches The Incredible Brain: Proven Science Behind Living a Longer, Healthier, More Impactful Life
ATLANTA, GA, UNITED STATES, September 12, 2025 /EINPresswire.com/ -- Neurologist Dr. Ryan Williamson Launches The Incredible Brain: Proven Science Behind Living a Longer, Healthier, More Impactful Life Board-certified neurologist, Navy veteran,...

EnvGPT: a specialized AI tool for climate, water, and soil science challenges
GA, UNITED STATES, September 12, 2025 /EINPresswire.com/ -- Large language models (LLMs) are transforming specialized fields, yet environmental science—with its complex terminology and interdisciplinary nature—has lagged behind. This study...

Deputy Minister Nomalungelo Gina embarks on official visit to Japan, 15 to 18 Sept
The Deputy Minister of Science, Technology and Innovation, Ms Nomalungelo Gina, will embark on an official visit to Japan from 15 to 18 September 2025 to strengthen cooperation in hydrogen energy and sustainable fuels. The Deputy Minister will...

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for...

Skytree Scientific Launches Beta Testing for Revolutionary LRA Plus™ Platform
Advanced automation and intelligent algorithms transform lightning risk assessment for modern infrastructure. ASHEVILLE, NC, UNITED STATES, September 11, 2025 /EINPresswire.com/ -- Skytree Scientific, a leading innovator in ClimateTech, is...

Semler Scientific, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; October 28, 2025 Deadline to file Lead Plaintiff Motion
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 11, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Semler Scientific, Inc. ("Semler Scientific" or the "Company") (NASDAQ: SMLR)...

Master Storyteller Shares the Science Behind Telling Stories That Activate Audiences
Sally Perkins explains how to capture hearts, minds and support for a noble cause in her new book From Story to Action INDIANAPOLIS, IN, UNITED STATES, September 11, 2025 /EINPresswire.com/ -- When people have a noble cause to advance -- whether...

Division of Applied Regulatory Science | Sampling of DARS Projects
Over-the-Counter Drug Research Evaluation of Sunscreen Active Ingredients DARS has conducted two randomized clinical trials which demonstrated systemic exposure of multiple commonly used sunscreen active ingredients under single and maximal use...
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $23.6 Million in Gross Proceeds
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer...
GenVivo Strengthens Oncology Leadership with Appointment of Noriyuki Kasahara, M.D., Ph.D., as Chief Scientific Officer
Scientific Advisory Board member, Dr. Noriyuki Kasahara, appointed Chief Scientific Officer of GenVivo, to accelerate the achievement of major clinical milestones SAN MARINO, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- GenVivo, Inc., a...
Waton Financial Limited Appoints Junfeng Qin as Lead Web3 Scientist to Drive Development of Next-Generation Brokerage Systems for Traditional and Digital Assets
HONG KONG, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Waton Financial Limited (NASDAQ: WTF) (“Waton” or the “Company”), a provider of securities brokerage and financial technology services, today announced the appointment of Mr. Junfeng Qin as Lead Web3...